Perfuse Therapeutics Shares Promising Phase IIa Results in Glaucoma and Diabetic Retinopathy
Could better blood flow be the key to treating glaucoma and diabetic retinopathy? New findings suggest it just might. Sometimes…
FDA Clears Ocugen’s Phase II/III Trial for Stargardt Disease Gene Therapy
Ocugen’s OCU410ST gene therapy gets another green light. Next stop: a Phase II/III trial. The U.S. Food and Drug Administration…
latest posts
